Health News Releases

October 03, 2023 11:57

Galderma announces progress with RelabotulinumtoxinA regulatory submissions

Galderma, the emerging pure-play dermatology category leader, announced today updates related to the regulatory progress of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA (Q

October 03, 2023 11:27

Boehringer Ingelheim and ZEISS join forces to early detect eye diseases and prevent vision loss

Boehringer Ingelheim and ZEISS Medical Technology announce today a long-term strategic collaboration to develop predictive analytics to enable early detection of eye diseases and prevent vision loss f

October 01, 2023 10:45

Organon Recognized on Fortune’s 2023 Change the World List for Leadership in Expanding Access to Contraceptive Choice

Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, has been named to Fortune’s 2023 Change the World list for its leadership in helping women and girls around the world t

September 27, 2023 10:40

Medisca Takes Steps to Protect its Innovative Technologies

Through decades of strategic research and development (“R&D”) investment, the Medisca name has become synonymous with innovative, customer-focused technologies. In compounding, for example, Medisca co

September 26, 2023 10:25

Korean Unicorn APR Files for Preliminary IPO Review on KRX

APR (https://www.apr-in.com/), a beauty-tech company APR (CEO Byung-hoon Kim) announced today that it filed for a preliminary review on the Korea Exchange (KRX) on September 22. Shinhan Securities

September 26, 2023 10:15

Aster Guardians Global Nursing Award 2024 is Now Open for Entry Worldwide, One Nurse Will Win the US $250,000 Award

In its continued efforts to recognize the contribution of nurses to humanity and the healthcare community, Aster DM Healthcare has announced the third edition of the Aster Guardians Global Nursing Awa

September 24, 2023 11:15

Kenvue to Announce Third Quarter 2023 Results on October 26, 2023

Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, will announce its financial results for the third quarter ending October 1, 2023, before market o

September 22, 2023 10:25

ReNAgade Therapeutics Named to the 2023 Endpoints 11

ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced that it has been named as one of the Endpoints 11 companies of 2023 (https://endpts.com/the-endpoi

September 21, 2023 10:00

41st Geumsan World K-Insam Festival to Kick Off with a Variety of Festivities on October 6

The 41st Geumsan World K-Insam Festival (https://www.kdischool.ac.kr/board.es?mid=a10603000000&bid=0011&list_no=16746&act=view) will take place in Geumsan from October 6 to 15, 2023, to promote the ef

September 20, 2023 16:48

MRM Health Reports Positive Topline Results from Phase 2a Clinical Study with MH002 in Mild-to-Moderate Ulcerative Colitis

MRM Health NV, a clinical-stage biopharmaceutical company focused on developing next-generation live microbiome consortia therapeutics, today reports positive topline results from its Phase 2a clinica

September 20, 2023 15:05

Blood Cancer: AOP Health Announces New Findings in Patients With Polycythemia Vera Published in Medical Journal Leukemia

AOP Orphan Pharmaceuticals GmbH (AOP Health) announced the publication of final results on the recently developed interferon therapy, ropeginterferon alfa-2b, in patients with polycythemia vera (PV) i

September 20, 2023 14:29

Merck Enters Two Strategic Collaborations to Strengthen AI-driven Drug Discovery

Merck, a leading science and technology company, today announced two new strategic drug discovery collaborations aimed at harnessing powerful artificial intelligence (AI)-driven design and discovery c

September 20, 2023 13:20

Julie Gerardi Joins Parse Biosciences as Vice President of Business Development

Parse Biosciences, (https://www.parsebiosciences.com/) a leading provider of accessible and scalable single cell sequencing solutions, today announced that Julie Gerardi has joined the company as vice

September 20, 2023 09:55

Takeda Commits Over $30 Million in Five New Global CSR Partnerships To Further Drive Health Impact in 92 Countries

Takeda (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) today announced five new partnerships to its Global Corporate Social Responsibility (CSR) Program, which contribute to strengthe

September 19, 2023 10:10

Pharmanovia Acquires Global Central Nervous System (CNS) Portfolio From Sanofi

PRESS RELEASE - FOR TRADE, BUSINESS AND MEDICAL MEDIA ONLY Pharmanovia, a global pharmaceutical company that commercialises novel medicines and revitalises, extends and expands the lifecycle of est

September 17, 2023 15:40

Biocytogen Officially Launches RenMice® Series

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) officially announces the RenMice® series, which includes a collection of independently developed, fully human antibody mice a

September 15, 2023 13:20

SK Capital Completes Strategic Investment in Ecopol

Ecopol S.p.A. (“Ecopol” or the “Company”), a leading developer and producer of innovative biodegradable films and delivery systems, announced today the completion of a strategic investment from affili

September 14, 2023 17:18

Boehringer Ingelheim receives SBTi validation for CO2 reduction targets

Boehringer Ingelheim, a leading research-driven biopharmaceutical company, said on Thursday it is well on track to achieve its 2030 emission reduction targets, and that it had received approval of tho

September 14, 2023 16:55

Ahead of UN General Assembly, pharmaceutical industry underscores need for pandemic preparedness plans to support innovation and equity

Ahead of discussions at the United Nations General Assembly (UNGA78), the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has warned that current pandemic preparednes

September 14, 2023 16:19

AstraZeneca advances UK clean heat and energy efficiencies with £100m commitment

Powering AstraZeneca’s transition to net zero, the Company has agreed a 15-year partnership with Future Biogas to establish the UK’s first unsubsidised industrial-scale supply of biomethane gas, and i

September 14, 2023 09:45

ReNAgade Therapeutics Appoints Laurie Stelzer as Chief Financial Officer

ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced the appointment of Laurie Stelzer as Chief Financial Officer. Ms. Stelzer most recently served as

September 13, 2023 11:20

KBI Biopharma, Inc. Expands Global Portfolio with Launch of SUREmAb™ for Faster Monoclonal Antibody Development and Manufacturing

KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced the launch of SUREmAb (https://www.kbibiopharma.com/suremab-efficient-antibody-development)™, an offering built on the robustnes

September 12, 2023 16:10

Monrol Announces Investment to Expand its n.c.a. Lu-177 Production Capacity

Eczacıbaşı Monrol Nuclear Products Co. (Monrol), one of the world’s leading radiopharmaceutical producers, has decided to invest 35 million Euros to increase its production capacity for non-carrier-ad

September 12, 2023 10:20

SINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection

Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that the Company has completed the phase I clinical trial for its

September 12, 2023 09:33

Takeda Announces Positive Topline Results from Phase 2b Study Evaluating TAK-279, a Highly Selective Oral TYK2 Inhibitor, for the Treatment of Active Psoriatic Arthritis

Takeda (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) today announced positive topline results from its randomized, double-blind, placebo-controlled, multiple-dose Phase 2b trial eva

News by Region

News by Industry